Stanley Druckenmiller Reata Pharmaceuticals Inc - Class A

Avg closing price

Price range

Increased shares by 9.1% (+57.7 Thousand shares) Q3 2021

Avg closing price $117.22

Price range $100.00 - $143.02

Sold 15.0% shares (-113 Thousand shares) Q2 2021

Avg closing price $112.92

Price range $78.27 - $151.29

Increased shares by 37.9% (+206 Thousand shares) Q4 2020

Avg closing price $131.41

Price range $102.03 - $184.62

Increased shares by 2.1% (+11 Thousand shares) Q3 2020

Avg closing price $124.95

Price range $93.53 - $163.34

Increased shares by 0.2% (+1 Thousand shares) Q2 2020

Avg closing price $152.02

Price range $126.30 - $176.56

Increased shares by 24.6% (+105 Thousand shares) Q1 2020

Avg closing price $193.06

Price range $124.16 - $247.74

Increased shares by 146.3% (+253 Thousand shares) Q4 2019

Avg closing price $182.82

Price range $74.57 - $217.92

New holding (+173 Thousand shares) Q3 2019

Avg closing price $84.86

Price range $71.26 - $95.75